What does APOTHEEK VAN SCHOUBROECK do?

APOTHEEK VAN SCHOUBROECK is a logistics company in Olen. Public Limited, started on 15 April 1991, 1 establishment.

What is the address of APOTHEEK VAN SCHOUBROECK?

The registered office of APOTHEEK VAN SCHOUBROECK is located at Oosterwijkseweg 11, 2250 Olen.

Is APOTHEEK VAN SCHOUBROECK still active?

Yes. According to the CBE (30 October 2026) APOTHEEK VAN SCHOUBROECK is active, legal situation “Normale toestand”, started on 15 April 1991.

Is APOTHEEK VAN SCHOUBROECK registered on Peppol?

Yes, APOTHEEK VAN SCHOUBROECK is registered on the Peppol network with ID 0208:0443887737.

What is the enterprise number of APOTHEEK VAN SCHOUBROECK?

The enterprise number of APOTHEEK VAN SCHOUBROECK is BE0443887737.

When was APOTHEEK VAN SCHOUBROECK founded?

APOTHEEK VAN SCHOUBROECK was founded on 15 April 1991.

Who are the directors of APOTHEEK VAN SCHOUBROECK?

According to the 2025 annual accounts, the directors of APOTHEEK VAN SCHOUBROECK are: K & T.

Is APOTHEEK VAN SCHOUBROECK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 April 1991; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK VAN SCHOUBROECK make in 2025?

APOTHEEK VAN SCHOUBROECK posted a profit after taxes of € 329,922 in financial year 2025.

What is the revenue of APOTHEEK VAN SCHOUBROECK?

As a small company, APOTHEEK VAN SCHOUBROECK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,101,080.

How much does an employee at APOTHEEK VAN SCHOUBROECK earn?

The average wage cost per full-time employee at APOTHEEK VAN SCHOUBROECK was € 74,100 in 2025: staff costs of € 533,834 for 7.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK VAN SCHOUBROECK have?

According to the 2025 annual accounts, APOTHEEK VAN SCHOUBROECK has 7.2 full-time equivalents (FTE).

APOTHEEK VAN SCHOUBROECK (Public Limited) - Olen

Dossier APOTHEEK VAN SCHOUBROECK, printed on 30 October 2026 from databakkes.be/en/0443887737/apotheek-van-schoubroeck. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VAN SCHOUBROECK from Olen, company number BE0443887737, closed financial year 2025 with a result of € 329,922 after tax. For that financial year APOTHEEK VAN SCHOUBROECK recorded a gross margin of € 1.1 million and equity of € 986,800. Compared with financial year 2024, the result moved from € 293,317 to € 329,922. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 986,800

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 329,922

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 625,778

▲ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 300,000 paid out

91 % of the profit went to the shareholders, mostly to K & T (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

7.2

▲ 0.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 533,834

▲ 15% vs 2024

€ 74,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 34,312

▲ 229% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 105,507

▲ 267% vs 2024

€ 17,289 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 417,840

▲ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 90,793

▲ 31% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 767,344 Gross margin 2022: € 767,344 First fiscal year in the series	€ 935,843 Gross margin 2023: € 935,843 ▲ 22% vs 2022 (€ 767,344) Favourable step	€ 989,275 Gross margin 2024: € 989,275 ▲ 6% vs 2023 (€ 935,843) Favourable step	€ 1,101,080 Gross margin 2025: € 1,101,080 ▲ 11% vs 2024 (€ 989,275) Favourable step	▲ 11%
Profit after taxes	€ 164,559 Profit after taxes 2022: € 164,559 First fiscal year in the series	€ 255,213 Profit after taxes 2023: € 255,213 ▲ 55% vs 2022 (€ 164,559) Favourable step	€ 293,317 Profit after taxes 2024: € 293,317 ▲ 15% vs 2023 (€ 255,213) Favourable step	€ 329,922 Profit after taxes 2025: € 329,922 ▲ 12% vs 2024 (€ 293,317) Favourable step	▲ 12%
Equity	€ 993,349 Equity 2022: € 993,349 First fiscal year in the series	€ 1,048,562 Equity 2023: € 1,048,562 ▲ 6% vs 2022 (€ 993,349) Favourable step	€ 956,879 Equity 2024: € 956,879 ▼ 9% vs 2023 (€ 1,048,562) Unfavourable step	€ 986,800 Equity 2025: € 986,800 ▲ 3% vs 2024 (€ 956,879) Favourable step	▲ 3%
Total debts	€ 703,260 Total debts 2022: € 703,260 First fiscal year in the series	€ 539,047 Total debts 2023: € 539,047 ▼ 23% vs 2022 (€ 703,260) Favourable step	€ 810,631 Total debts 2024: € 810,631 ▲ 50% vs 2023 (€ 539,047) Unfavourable step	€ 996,285 Total debts 2025: € 996,285 ▲ 23% vs 2024 (€ 810,631) Unfavourable step	▲ 23%
Cash	€ 263,826 Cash 2022: € 263,826 First fiscal year in the series	€ 302,643 Cash 2023: € 302,643 ▲ 15% vs 2022 (€ 263,826) Favourable step	€ 476,155 Cash 2024: € 476,155 ▲ 57% vs 2023 (€ 302,643) Favourable step	€ 625,778 Cash 2025: € 625,778 ▲ 31% vs 2024 (€ 476,155) Favourable step	▲ 31%
Land & buildings	€ 49,116 Land & buildings 2022: € 49,116 First fiscal year in the series	€ 34,279 Land & buildings 2023: € 34,279 ▼ 30% vs 2022 (€ 49,116) Unchanged	€ 22,202 Land & buildings 2024: € 22,202 ▼ 35% vs 2023 (€ 34,279) Unchanged	€ 12,715 Land & buildings 2025: € 12,715 ▼ 43% vs 2024 (€ 22,202) Unchanged	▼ 43%
Retained profit	€ 540,911 Retained profit 2022: € 540,911 First fiscal year in the series	€ 596,124 Retained profit 2023: € 596,124 ▲ 10% vs 2022 (€ 540,911) Favourable step	€ 504,441 Retained profit 2024: € 504,441 ▼ 15% vs 2023 (€ 596,124) Unfavourable step	€ 534,363 Retained profit 2025: € 534,363 ▲ 6% vs 2024 (€ 504,441) Favourable step	▲ 6%
Dividend	€ 175,000 Dividend 2022: € 175,000 First fiscal year in the series	€ 200,000 Dividend 2023: € 200,000 ▲ 14% vs 2022 (€ 175,000) Unchanged	€ 385,000 Dividend 2024: € 385,000 ▲ 93% vs 2023 (€ 200,000) Unchanged	€ 300,000 Dividend 2025: € 300,000 ▼ 22% vs 2024 (€ 385,000) Unchanged	▼ 22%
Bank debt	€ 10,011 Bank debt 2022: € 10,011 First fiscal year in the series	€ 11,819 Bank debt 2023: € 11,819 ▲ 18% vs 2022 (€ 10,011) Unfavourable step	€ 28,771 Bank debt 2024: € 28,771 ▲ 143% vs 2023 (€ 11,819) Unfavourable step	€ 105,507 Bank debt 2025: € 105,507 ▲ 267% vs 2024 (€ 28,771) Unfavourable step	▲ 267%
Balance sheet total	€ 1,696,608 Balance sheet total 2022: € 1,696,608 First fiscal year in the series	€ 1,587,608 Balance sheet total 2023: € 1,587,608 ▼ 6% vs 2022 (€ 1,696,608) Unchanged	€ 1,767,510 Balance sheet total 2024: € 1,767,510 ▲ 11% vs 2023 (€ 1,587,608) Unchanged	€ 1,983,085 Balance sheet total 2025: € 1,983,085 ▲ 12% vs 2024 (€ 1,767,510) Unchanged	▲ 12%
Employees (FTE)	5.6 Employees (FTE) 2022: 5.6 First fiscal year in the series	5.7 Employees (FTE) 2023: 5.7 ▲ 0.1 vs 2022 (5.6) Unchanged	6.3 Employees (FTE) 2024: 6.3 ▲ 0.6 vs 2023 (5.7) Unchanged	7.2 Employees (FTE) 2025: 7.2 ▲ 0.9 vs 2024 (6.3) Unchanged	▲ 0.9

Key figures of APOTHEEK VAN SCHOUBROECK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VAN SCHOUBROECK?

What happened at APOTHEEK VAN SCHOUBROECK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 329,922 (▲ 12% vs 2024). Source: NBB ↗
Oct 18, 1991 New establishment in Olen. KBO
Apr 15, 1991 Start of the company according to the CBE. KBO

In short

From € 164,559 profit in 2022 to € 329,922 profit in 2025.

Paid € 365,820 in corporate taxes since 2022.

Best year ever: 2025, with € 329,922 profit.

On average € 152,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

K & T 100%

APOTHEEK VAN SCHOUBROECK

Behind APOTHEEK VAN SCHOUBROECK is K & T. The shares are held by K & T (100%).

Directors

According to the 2025 annual accounts

K & T

Director · represented by Antoon Van Schoubroeck

Also active at: Apotheek Lierseweg

Shareholders

K & T

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Oosterwijkseweg 11

2250 Olen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0443.887.737

VAT number

BE 0443.887.737

Registered office

Oosterwijkseweg 11, 2250 Olen

Names & denominations

APOTHEEK VAN SCHOUBROECK

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

15 April 1991

Peppol

Active · Active since 18 Nov 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VAN SCHOUBROECK

Financials

What happened to APOTHEEK VAN SCHOUBROECK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions